{
    "clinical_study": {
        "@rank": "21630", 
        "arm_group": {
            "arm_group_label": "Isoflurane administration", 
            "arm_group_type": "Experimental", 
            "description": "Isoflurane dosage titration the 10 min-inhalation of each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine Isoflurane's dose-dependent effect on left\n      ventricular (LV) function in cardiac surgery. The change of tissue Doppler imaging (TDI) of\n      lateral mitral valve annular velocity at three different isoflurane concentrations would be\n      analyzed by using intraoperative transesophageal echocardiography (TEE) in cardiac surgery\n      patients."
        }, 
        "brief_title": "Effect of Isoflurane on Tissue Doppler Imaging of Mitral Annulus During Cardiac Surgery", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Valvular Heart Disease", 
            "Ischemic Heart Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Heart Diseases", 
                "Heart Valve Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Tissue Doppler imaging (TDI) of mitral annular velocity during the cardiac cycle has been\n      introduced as a reliable method for analysis of systolic and diastolic LV ling-axix\n      function, efficacy of diastolic TDI profile, including early early relaxation (E')and atrial\n      contraction (A') and has been suggested to be useful in predicting the postoperative\n      clinical outcomes and the impact of isoflurane on LV diastolic function.\n\n      Isoflurane is widely used in cardiac surgery patients due to its beneficial effects, but\n      many studies have shown that isoflurane reduces myocardial contractility in a dose-dependent\n      manner, and compromises left ventricular (LV) function.\n\n      The investigators hypothesized that isoflurane, even at a clinical dosage, would affects\n      intraoperative LV systolic function in a dose-dependent manner and thus produce significant\n      changes int the TDI profiles of mitral annular velocity.\n\n      So the investigators planned to study the changes in TDI profiles of lateral mitral annular\n      velocity at the clinical isoflurane dosage during remifentanil based anesthesia for cardiac\n      surgery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients undergoing cardiac surgery\n\n        Exclusion Criteria:\n\n          -  low ejection fraction < 50% in preoperative transthoracic echocardiography\n\n          -  atrial fibrillation\n\n          -  pacemaker\n\n          -  pericardial and infiltrative myocardial disease\n\n          -  mitral annular calcification, surgical rings, prosthetic mitral valves\n\n          -  lateral left ventricular regional wall motion abnormality\n\n          -  esophageal spasm, stricture, laceration, perforation, and diverticulum diaphragmatic\n             hernia\n\n          -  history of extensive radiation to mediastinum\n\n          -  upper gastrointestinal bleeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01819012", 
            "org_study_id": "KUH1160052"
        }, 
        "intervention": {
            "arm_group_label": "Isoflurane administration", 
            "description": "Isoflurane dosage titration Comparisons of the effect of the 10 min-inhalation of each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC (T1, T2 and T3, respectively) to determine the changes in following parameters\nTDI of lateral mitral annulus at systole (S'), early filling (E') and atrial contraction (A')\ntransmitral flow Doppler at early filling (E'), atrial contraction (A'), deceleration time\nLV-ejection fraction (EF)\nbispectral index (BIS)\nphenylephrine-infusion rate\npressure derived hemodymic parameters", 
            "intervention_name": "Isoflurane", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Isoflurane"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Isoflurane", 
            "mitral valve annular velocity", 
            "tissue Doppler imaging", 
            "Monitoring", 
            "echocardiography"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "contact": {
                "email": "20110360@kuh.ac.kr", 
                "last_name": "Seong-Ho Lee", 
                "phone": "82-2-2030-6522"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "143-729"
                }, 
                "name": "Konkuk University Medical Center"
            }, 
            "investigator": {
                "last_name": "Tae-Yop Kim, MD PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect of Isoflurane on Tissue Doppler Imaging of Mitral Annulus During Cardiac Surgery", 
        "overall_contact": {
            "last_name": "Tae-Yop Kim, MD, PhD", 
            "phone": "82-10-8811-6942"
        }, 
        "overall_official": {
            "affiliation": "Konkuk University", 
            "last_name": "Tae-Yop Kim, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "By using pulsed Doppler with the sample volume positioned at the lateral mitral valve (MV)ring in the midesophageal 4-chamber view, S' would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC (T1, T2 and T3, respectively)", 
                "measure": "Peak mitral annular velocity during systole(S')", 
                "safety_issue": "No", 
                "time_frame": "after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC  and 2.0 MAC"
            }, 
            {
                "description": "By using pulsed Doppler with the sample volume positioned at the lateral MV ring in the midesophageal 4-chamber view, E' would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC(T1, T2 and T3, respectively)", 
                "measure": "Peak mitral annular velocity during early diastole(E')", 
                "safety_issue": "No", 
                "time_frame": "after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC"
            }, 
            {
                "description": "By using pulsed Doppler with the sample volume positioned at the lateral MV ring in the midesophageal 4-chamber view, A' would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC(T1, T2 and T3, respectively)", 
                "measure": "Peak mitral annular velocity during atrial contraction(A')", 
                "safety_issue": "No", 
                "time_frame": "after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC  and 2.0 MAC"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01819012"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Konkuk University Medical Center", 
            "investigator_full_name": "Tae-Yop Kim, MD PhD", 
            "investigator_title": "Professor of Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "By using modified Simpson technique in the midesophageal 4-chamber view, EF would be determined just after the 10 min-exposure to each concentration of isoflurane 1.0 MAC, 1.5 MAC  and 2.0 MAC", 
                "measure": "ejection fraction(EF)", 
                "safety_issue": "No", 
                "time_frame": "after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC"
            }, 
            {
                "description": "BIS would be determined just after the 10 min-exposure to each concentration of isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC", 
                "measure": "bispectral index(BIS)", 
                "safety_issue": "No", 
                "time_frame": "after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC"
            }, 
            {
                "description": "By using pulsed Doppler with the sample volume positioned at the IMV opening in the midesophageal 4-chamber view, E' would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC(T1, T2 and T3, respectively)", 
                "measure": "peak velocity of mitral inflow during early relaxation(E)", 
                "safety_issue": "No", 
                "time_frame": "after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC"
            }, 
            {
                "description": "By using pulsed Doppler with the sample volume positioned at the tip of MV opening in the midesophageal 4-chamber view, \"A\" would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC(T1, T2 and T3, respectively)", 
                "measure": "peak velocity of mitral inflow during atrial contraction(A)", 
                "safety_issue": "No", 
                "time_frame": "after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC"
            }
        ], 
        "source": "Konkuk University Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Konkuk University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}